|
Press Releases |
|
 |
|
Sunday, May 5, 2024 |
|
健倍苗苗发布盈喜 |
健倍苗苗(保健)有限公司(「健倍苗苗」或「公司」;股份代号:2161,连同其附属公司统称「集团」)为香港品牌保健品的领先营销商及分销商,集团发布盈喜预告。根据集团对截至二零二四年三月三十一日止年度的未经审核综合管理账目的初步审阅及公司董事会目前可得的资料,集团预期截至二零二四年三月三十一日止年度的股东应占综合溢利(「综合溢利」)将较去年同期增加不少于120%。 more info >> |
|
健倍苗苗發佈盈喜 |
健倍苗苗(保健)有限公司 (「健倍苗苗」或「公司」;股份代號:2161,連同其附屬公司統稱「集團」) 為香港品牌保健品的領先營銷商及分銷商,集團發佈盈喜預告。根據集團對截至二零二四年三月三十一日止年度的未經審核綜合管理賬目的初步審閱及公司董事會目前可得的資料,集團預期截至二零二四年三月三十一日止年度的股東應佔綜合溢利(「綜合溢利」)將較去年同期增加不少於120%。 more info >> |
|
JBM Healthcare Issues Positive Profit Alert |
JBM (Healthcare) Limited has announced a positive profit alert. Based on a preliminary review of the unaudited consolidated management accounts of the Group for the financial year ended 31 March 2024 and the information currently available to the board of directors of the Company, the Group is expected to record an increase in the consolidated profit attributable to shareholders for the year ended 31 March 2024 ("Consolidated Profit") by not less than 120% as compared to that for the same period last year. more info >> |
|
Wednesday, November 22, 2023 |
|
健倍苗苗公布二零二四财年中期业绩 |
健倍苗苗(保健)有限公司 (「健倍苗苗」或「公司」;股份代号:2161,连同其附属公司统称「集团」) 为香港品牌保健品的领先营销商及分销商,集团今天公布截至二零二三年九月三十日止六个月(「报告期」)的中期业绩。 more info >> |
|
健倍苗苗公佈二零二四財年中期業績 |
健倍苗苗(保健)有限公司 (「健倍苗苗」或「公司」;股份代號:2161,連同其附屬公司統稱「集團」) 為香港品牌保健品的領先行銷商及分銷商,集團今天公佈截至二零二三年九月三十日止六個月(「報告期」)的中期業績。 more info >> |
|
JBM Healthcare Announces FY2024 Interim Results |
JBM (Healthcare) Limited ("JBM Healthcare" or the "Company"; Stock Code: 2161, together with its subsidiaries, the "Group"), a leading branded healthcare products marketer and distributor in Hong Kong, today announced the interim results of the Group for the six months ended 30 September 2023 (the "Reporting Period"). more info >> |
|
Thursday, June 15, 2023 |
|
健倍苗苗公布二零二三财年全年业绩 |
健倍苗苗(保健)有限公司(「健倍苗苗」或「公司」;股份代号:2161,连同其附属公司统称「集团」)为香港品牌保健品的领先营销商及分销商,集团今天公布截至二零二三年三月三十一日止年度(「二零二三财年」或「报告期」)的全年业绩。 more info >> |
|
健倍苗苗公佈二零二三財年全年業績 |
健倍苗苗(保健)有限公司(「健倍苗苗」或「公司」;股份代號:2161,連同其附屬公司統稱「集團」)為香港品牌保健品的領先營銷商及分銷商,集團今天公佈截至二零二三年三月三十一日止年度(「二零二三財年」或「報告期」)的全年業績。 more info >> |
|
JBM Healthcare Announces FY2023 Annual Results |
JBM (Healthcare) Limited ("JBM Healthcare" or the "Company"; Stock Code: 2161, together with its subsidiaries, the "Group"), a leading branded healthcare products marketer and distributor in Hong Kong, today announced the annual results of the Group for the year ended 31 March 2023 ("FY2023" or the "Reporting Period"). more info >> |
|
Friday, November 25, 2022 |
|
健倍苗苗公布二零二三财年中期业绩 |
健倍苗苗(保健)有限公司 (「健倍苗苗」或「集团」;股份代号:2161.HK) 为香港领先的品牌医疗保健品推广商及分销商,集团今天公布截至二零二二年九月三十日止六个月(「报告期」)的中期业绩。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Soligenix's Leadership Aims to Drive Growth in Rare Disease Markets in 2025 and 2026
Feb 22, 2025 03:50 HKT/SGT
|
|
|
Carl Zeiss Honors EuroEyes International for Exceptional Milestone in AT LISA(R) Trifocal Lens Implantations
Feb 21, 2025 23:22 HKT/SGT
|
|
|
卡爾蔡司表揚德視佳國際於AT LISA(R)三焦晶體植入量方面的非凡里程碑
Feb 21, 2025 23:19 HKT/SGT
|
|
|
Dollamur 宣布獲得世界摔角聯盟(UWW)認證,許可期限至 2028 年
Feb 21, 2025 23:18 HKT/SGT
|
|
|
Alexis Mc Allister Announces as Jeton's Latest Brand Ambassador
Feb 21, 2025 23:00: JST
|
|
|
Alexis Mc Allister Announces as Jeton's Latest Brand Ambassador
Feb 21, 2025 23:00 HKT/SGT
|
|
|
蜜雪集團在港招股 全球最大現製飲品企業推進「全球一體化」
Feb 21, 2025 22:11 HKT/SGT
|
|
|
全球最大現製飲品巨頭!蜜雪集團今起招股
Feb 21, 2025 22:10 HKT/SGT
|
|
|
Dollamur Announces United World Wrestling Approval Through 2028
Feb 21, 2025 22:04 HKT/SGT
|
|
|
Yashaa Global Capital Secures Financial Services Permission to Establish a Global Sports VC Fund
Feb 21, 2025 22:00 HKT/SGT
|
|
|
NaaS Technology Launches $10 Million Share Repurchase Plan Boosting Market Confidence
Feb 21, 2025 21:09 HKT/SGT
|
|
|
全球最大可堆疊分佈式光儲一體機企業 思格新能源衝刺港股IPO
Feb 21, 2025 20:29 HKT/SGT
|
|
|
全球最大可堆叠分布式光储一体机企业 思格新能源冲刺港股IPO
Feb 21, 2025 20:25 HKT/SGT
|
|
|
四個香港設計師品牌亮相倫敦時裝周
Feb 21, 2025 19:07 HKT/SGT
|
|
|
四个香港设计师品牌亮相伦敦时装周
Feb 21, 2025 18:59 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|